Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-071911
Filing Date
2023-12-20
Accepted
2023-12-20 16:41:48
Documents
1
Period of Report
2023-12-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6325
  Complete submission text file 0000950170-23-071911.txt   7805
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Castelli Jeff (Reporting) CIK: 0001569225 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33497 | Film No.: 231501806